Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Microbially Driven TLR5-Dependent Signaling Governs Distal Malignant Progression through Tumor-Promoting Inflammation
Melanie R. Rutkowski, Tom L. Stephen, Nikolaos Svoronos, et al.
Cancer Cell (2014) Vol. 27, Iss. 1, pp. 27-40
Open Access | Times Cited: 277

Showing 1-25 of 277 citing articles:

The human tumor microbiome is composed of tumor type–specific intracellular bacteria
Deborah Nejman, Ilana Livyatan, Garold Fuks, et al.
Science (2020) Vol. 368, Iss. 6494, pp. 973-980
Open Access | Times Cited: 1598
The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression
Smruti Pushalkar, Mautin Hundeyin, Donnele Daley, et al.
Cancer Discovery (2018) Vol. 8, Iss. 4, pp. 403-416
Open Access | Times Cited: 1076
Characteristics and Significance of the Pre-metastatic Niche
Yang Liu, Xuetao Cao
Cancer Cell (2016) Vol. 30, Iss. 5, pp. 668-681
Open Access | Times Cited: 968
Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors
Jonathan M. Pitt, Marie Vétizou, Romain Daillère, et al.
Immunity (2016) Vol. 44, Iss. 6, pp. 1255-1269
Open Access | Times Cited: 929
Microbiota: a key orchestrator of cancer therapy
Soumen Roy, Giorgio Trinchieri
Nature reviews. Cancer (2017) Vol. 17, Iss. 5, pp. 271-285
Closed Access | Times Cited: 787
Obesity and Cancer Mechanisms: Tumor Microenvironment and Inflammation
Neil M. Iyengar, Ayca Gucalp, Andrew J. Dannenberg, et al.
Journal of Clinical Oncology (2016) Vol. 34, Iss. 35, pp. 4270-4276
Open Access | Times Cited: 745
Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects
Romain Daillère, Marie Vétizou, Nadine Waldschmitt, et al.
Immunity (2016) Vol. 45, Iss. 4, pp. 931-943
Open Access | Times Cited: 736
The Intestinal Microbiota in Colorectal Cancer
Herbert Tilg, Timon E. Adolph, Romana R. Gerner, et al.
Cancer Cell (2018) Vol. 33, Iss. 6, pp. 954-964
Open Access | Times Cited: 637
The role of the microbiome in cancer development and therapy
Aadra P. Bhatt, Matthew R. Redinbo, Scott J. Bultman
CA A Cancer Journal for Clinicians (2017) Vol. 67, Iss. 4, pp. 326-344
Open Access | Times Cited: 548
Microbiome and Anticancer Immunosurveillance
Laurence Zitvogel, Maha Ayyoub, Bertrand Routy, et al.
Cell (2016) Vol. 165, Iss. 2, pp. 276-287
Open Access | Times Cited: 407
γδ T cells: pleiotropic immune effectors with therapeutic potential in cancer
Bruno Silva‐Santos, Sofia Mensurado, Seth B. Coffelt
Nature reviews. Cancer (2019) Vol. 19, Iss. 7, pp. 392-404
Open Access | Times Cited: 326
Natural and therapy-induced immunosurveillance in breast cancer
Guido Kroemer, Laura Senovilla, Lorenzo Galluzzi, et al.
Nature Medicine (2015) Vol. 21, Iss. 10, pp. 1128-1138
Closed Access | Times Cited: 276
Microbes and Cancer
Amiran Dzutsev, Jonathan H. Badger, Ernesto Peréz-Chanona, et al.
Annual Review of Immunology (2017) Vol. 35, Iss. 1, pp. 199-228
Closed Access | Times Cited: 245
Demystifying the manipulation of host immunity, metabolism, and extraintestinal tumors by the gut microbiome
Ziying Zhang, Haosheng Tang, Peng Chen, et al.
Signal Transduction and Targeted Therapy (2019) Vol. 4, Iss. 1
Open Access | Times Cited: 207
The hematopoietic stem cell niche in homeostasis and disease
Laura M. Calvi, Daniel C. Link
Blood (2015) Vol. 126, Iss. 22, pp. 2443-2451
Open Access | Times Cited: 204
The negative impact of antibiotics on outcomes in cancer patients treated with immunotherapy: a new independent prognostic factor?
Arielle Elkrief, Lisa Derosa, Guido Kroemer, et al.
Annals of Oncology (2019) Vol. 30, Iss. 10, pp. 1572-1579
Open Access | Times Cited: 193
The emerging roles of γδ T cells in cancer immunotherapy
Sofia Mensurado, Rafael Blanco-Domínguez, Bruno Silva‐Santos
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 3, pp. 178-191
Closed Access | Times Cited: 190
Exosomes miR-126a released from MDSC induced by DOX treatment promotes lung metastasis
Zhenghao Deng, Yuan Rong, Yan Teng, et al.
Oncogene (2016) Vol. 36, Iss. 5, pp. 639-651
Open Access | Times Cited: 188
Toll-like receptor stimulation in cancer: A pro- and anti-tumor double-edged sword
Marion Dajon, Kristina Iribarren, Isabelle Cremer
Immunobiology (2016) Vol. 222, Iss. 1, pp. 89-100
Closed Access | Times Cited: 187
Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progression
Arianna Calcinotto, Arianna Brevi, Marta Chesi, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 180
Tumor Cell–Independent Estrogen Signaling Drives Disease Progression through Mobilization of Myeloid-Derived Suppressor Cells
Nikolaos Svoronos, Alfredo Perales‐Puchalt, Michael J. Allegrezza, et al.
Cancer Discovery (2016) Vol. 7, Iss. 1, pp. 72-85
Open Access | Times Cited: 177
Exosomes Produced by Mesenchymal Stem Cells Drive Differentiation of Myeloid Cells into Immunosuppressive M2-Polarized Macrophages in Breast Cancer
Subir Biswas, Gunjan Mandal, Sougata Roy Chowdhury, et al.
The Journal of Immunology (2019) Vol. 203, Iss. 12, pp. 3447-3460
Open Access | Times Cited: 175
Galectin-1: A Jack-of-All-Trades in the Resolution of Acute and Chronic Inflammation
Victoria Sundblad, Luciano Gastón Morosi, Jorge Geffner, et al.
The Journal of Immunology (2017) Vol. 199, Iss. 11, pp. 3721-3730
Open Access | Times Cited: 173
Preexisting Commensal Dysbiosis Is a Host-Intrinsic Regulator of Tissue Inflammation and Tumor Cell Dissemination in Hormone Receptor–Positive Breast Cancer
Claire Buchta Rosean, Raegan R. Bostic, Joshua C.M. Ferey, et al.
Cancer Research (2019) Vol. 79, Iss. 14, pp. 3662-3675
Open Access | Times Cited: 167
The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors through Inhibition of STING Signaling
Eslam Mohamed, Rosa A. Sierra, Jimena Trillo-Tinoco, et al.
Immunity (2020) Vol. 52, Iss. 4, pp. 668-682.e7
Open Access | Times Cited: 158
Page 1 - Next Page

Scroll to top